Traders Busy as Ohr Pharmaceutical Inc (OHRP) Reels on Data

OHR Pharmaceutical Inc (OHRP) touched a multi-year low today

by

Published on Mar 27, 2015 at 10:50 AM
Updated on Apr 20, 2015 at 5:32 PM

OHR Pharmaceutical Inc (NASDAQ:OHRP) is getting bloodied up this morning, after the biotech firm's experimental eye drug fell short of its goal during a mid-stage trial. At last check, the stock was down nearly 65% at $3.08, and fresh off a multi-year low of $2.90. Shifting gears, OHRP options are flying off the shelves at 12 times the expected intraday rate.

A number of front-month calls are in the crosshairs. Specifically, the April 2.50, 10, 12.50, and 15 strikes are experiencing notable volume, with possible buy-to-open activity detected at the in-the-money strike. However, OHRP's most active option is the April 7.50 put, which is seeing a mix of buying and selling activity.

One group that's likely cheering today's technical breakdown is short sellers. Short interest on OHR Pharmaceutical Inc (NASDAQ:OHRP) grew 25% during the two most recent reporting periods, and now makes up 15.5% of the equity's total float. However, additional short selling isn't currently an option, as OHRP has been placed on the short-sale restricted list.


A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....
Tiffany Stock Drops as Takeover Talks Dissipate
LVMH was to acquire Tiffany & Co in a billion-dollar deal
Coty Stock Glows Up with Possible Kardashian Cosmetics Line
The trendy cosmetics company is in talks with reality TV star Kim Kardashian West over a line of beauty products
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.